These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 39143009
1. Bisdemethoxycurcumin Augments Docetaxel Efficacy for Treatment of Prostate Cancer. Song Y, Ruan J, Liu S, Yu H. Biol Pharm Bull; 2024; 47(8):1437-1446. PubMed ID: 39143009 [Abstract] [Full Text] [Related]
2. Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition. Tamaki H, Harashima N, Hiraki M, Arichi N, Nishimura N, Shiina H, Naora K, Harada M. Oncotarget; 2014 Nov 30; 5(22):11399-412. PubMed ID: 25333266 [Abstract] [Full Text] [Related]
3. Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models. Festuccia C, Gravina GL, D'Alessandro AM, Muzi P, Millimaggi D, Dolo V, Ricevuto E, Vicentini C, Bologna M. Endocr Relat Cancer; 2009 Jun 30; 16(2):401-13. PubMed ID: 19153211 [Abstract] [Full Text] [Related]
4. A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cells. Wei MM, Zhao SJ, Dong XM, Wang YJ, Fang C, Wu P, Song GQ, Gao JN, Huang ZH, Xie T, Zhou JL. J Ethnopharmacol; 2021 Mar 01; 267():113467. PubMed ID: 33058923 [Abstract] [Full Text] [Related]
5. Bisdemethoxycurcumin Induces Cell Apoptosis and Inhibits Human Brain Glioblastoma GBM 8401/Luc2 Cell Xenograft Tumor in Subcutaneous Nude Mice In Vivo. Hsia TC, Peng SF, Chueh FS, Lu KW, Yang JL, Huang AC, Hsu FT, Wu RS. Int J Mol Sci; 2022 Jan 04; 23(1):. PubMed ID: 35008959 [Abstract] [Full Text] [Related]
6. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway. Singh SK, Banerjee S, Acosta EP, Lillard JW, Singh R. Oncotarget; 2017 Mar 07; 8(10):17216-17228. PubMed ID: 28212547 [Abstract] [Full Text] [Related]
7. Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line. Eftekhari S, Montazeri H, Tarighi P. Eur J Pharmacol; 2020 Jul 05; 878():173102. PubMed ID: 32283060 [Abstract] [Full Text] [Related]
8. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells. Ishii K, Matsuoka I, Kajiwara S, Sasaki T, Miki M, Kato M, Kanda H, Arima K, Shiraishi T, Sugimura Y. J Cancer Res Clin Oncol; 2018 Jan 05; 144(1):89-98. PubMed ID: 29098395 [Abstract] [Full Text] [Related]
9. Bisdemethoxycurcumin-induced S phase arrest through the inhibition of cyclin A and E and induction of apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathways in human lung cancer NCI H460 cells. Yang ST, Huang AC, Tang NY, Liu HC, Liao CL, Ji BC, Chou YC, Yang MD, Lu HF, Chung JG. Environ Toxicol; 2016 Dec 05; 31(12):1899-1908. PubMed ID: 26370218 [Abstract] [Full Text] [Related]
10. A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL. Hwang JJ, Kim YS, Kim T, Kim MJ, Jeong IG, Lee JH, Choi J, Jang S, Ro S, Kim CS. Invest New Drugs; 2012 Aug 05; 30(4):1434-42. PubMed ID: 21773733 [Abstract] [Full Text] [Related]
11. The antiproliferative function of violacein-like purple violet pigment (PVP) from an Antarctic Janthinobacterium sp. Ant5-2 in UV-induced 2237 fibrosarcoma. Mojib N, Nasti TH, Andersen DT, Attigada VR, Hoover RB, Yusuf N, Bej AK. Int J Dermatol; 2011 Oct 05; 50(10):1223-33. PubMed ID: 21790550 [Abstract] [Full Text] [Related]
12. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells. Yoo J, Park SS, Lee YJ. J Cell Biochem; 2008 Aug 01; 104(5):1636-46. PubMed ID: 18404675 [Abstract] [Full Text] [Related]
13. Alpha-tomatine synergises with paclitaxel to enhance apoptosis of androgen-independent human prostate cancer PC-3 cells in vitro and in vivo. Lee ST, Wong PF, Hooper JD, Mustafa MR. Phytomedicine; 2013 Nov 15; 20(14):1297-305. PubMed ID: 23920276 [Abstract] [Full Text] [Related]
14. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization. Li Y, Zhang B, Xiang L, Xia S, Kucuk O, Deng X, Boise LH, Dong JT. Theranostics; 2020 Nov 15; 10(17):7656-7670. PubMed ID: 32685011 [Abstract] [Full Text] [Related]
15. Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia. Nomura T, Yamasaki M, Hirai K, Inoue T, Sato R, Matsuura K, Moriyama M, Sato F, Mimata H. Mol Cancer; 2013 Apr 08; 12():27. PubMed ID: 23566222 [Abstract] [Full Text] [Related]
16. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo. Wang J, Lu Z, Wu C, Li Y, Kong Y, Zhou R, Shi K, Guo J, Li N, Liu J, Song W, Wang H, Zhu M, Xu H. Prostate; 2019 Jan 08; 79(1):62-72. PubMed ID: 30242862 [Abstract] [Full Text] [Related]
17. Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis. Goc A, Kochuparambil ST, Al-Husein B, Al-Azayzih A, Mohammad S, Somanath PR. BMC Cancer; 2012 Sep 14; 12():409. PubMed ID: 22974127 [Abstract] [Full Text] [Related]
18. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells. Wong HC, Wong CC, Sagineedu SR, Loke SC, Lajis NH, Stanslas J. Cell Biol Toxicol; 2014 Oct 14; 30(5):269-88. PubMed ID: 25070834 [Abstract] [Full Text] [Related]
19. Phenoxodiol inhibits growth of metastatic prostate cancer cells. Aguero MF, Venero M, Brown DM, Smulson ME, Espinoza LA. Prostate; 2010 Aug 14; 70(11):1211-21. PubMed ID: 20564423 [Abstract] [Full Text] [Related]
20. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer. Yan J, Wang Y, Jia Y, Liu S, Tian C, Pan W, Liu X, Wang H. Biomed Pharmacother; 2017 Apr 14; 88():374-383. PubMed ID: 28122302 [Abstract] [Full Text] [Related] Page: [Next] [New Search]